# Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions

> **NCT06297174** · PHASE1 · UNKNOWN · sponsor: **Pharma Nueva** · enrollment: 44 (estimated)

## Conditions studied

- Healthy Vollunteer

## Interventions

- **DRUG:** Racecadotril 100 mg Capsules
- **DRUG:** HIDRASEC®

## Key facts

- **NCT ID:** NCT06297174
- **Lead sponsor:** Pharma Nueva
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-08-26
- **Primary completion:** 2024-09-17
- **Final completion:** 2024-09-20
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06297174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06297174, "Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06297174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*